Description
Basic introduction
Tirzepatide is a synthetic peptide investigated through both GIP and GLP-1 receptor pathways. Its structure includes a lipid modification, which is relevant to the pharmacological preparation described in the scientific literature.
The research spans receptor assays, animal models and clinical studies. These evidence levels should remain separate: a receptor response characterizes one aspect of a molecule, while a clinical study concerns a defined formulation, population and protocol.
Mechanism of action · Research context
GIP receptor response
Tirzepatide was characterized as a GIP receptor agonist. Receptor-specific assays help define this activity independently of its response at the GLP-1 receptor.
GLP-1 receptor response
GLP-1 receptor activity provides a second experimental pathway. Comparing signaling in matched assay systems is more informative than assuming equal activity at both receptors from the dual-agonist label alone.
Integrated metabolic effects
Whole-system responses involve more than receptor activation. The discovery program examined glucose-dependent insulin secretion and metabolic outcomes across several experimental settings.
Extended research considerations
Receptor assay controls
Identify the receptor expression system and readout. Differences in receptor abundance, assay timing or signal amplification can affect comparisons between GIP and GLP-1 responses.
Formulation and exposure
Lipid modification influences the tested preparation. Analytical identity, aggregation and compatibility with the assay medium are separate from the receptor-response result.
Clinical evidence context
Clinical trials evaluate specific pharmaceutical preparations. Their outcomes do not certify the identity, sterility or clinical suitability of a research product sold independently of those studies.
Material and packaging
Available kit specifications: 5 mg × 10 vials; 10 mg × 10 vials; 15 mg × 10 vials; 20 mg × 10 vials; 30 mg × 10 vials; 40 mg × 10 vials; 50 mg × 10 vials; 60 mg × 10 vials; 100 mg × 10 vials; 120 mg × 10 vials. Select an option above to view its current price and availability.
Storage and handling
Source-listed storage condition: Store at 20°C to 25°C (Do not freeze). Follow the handling instructions supplied with the actual batch and your laboratory's procedures.
Analytical documentation
Reference analytical documents are available with this listing. Check the material identity, batch number and test date against the batch supplied; contact us for current batch documentation.
Scientific references
These publications describe the studied molecules and experimental models. They do not certify the identity, quality or effects of a particular supplied batch.
- Discovery and experimental characterization of LY3298176
- Phase 2 tirzepatide clinical research
View report
View report
Milo Hale –
I run blood sugar and weight lab tests, TR10 makes all my test data far more stable than cheap peptide brands. It’s over 99% pure so random impurities won’t mess up my readings. I store bottles at normal room temp; freezing one vial once cut most of its working effect. Mixed liquid stays clear for 5 days cold, perfect for my weekly mouse injections.
Nora Vale –
I tested three different peptide brands side by side, TR10 has the steadiest test performance. Its chemical data matches our lab database so I skip extra ingredient checks. I only mix one vial weekly to avoid wasting diluted peptide liquid.
Freya Maeve –
The powder remains loose and never hardens into chunks at the bottle bottom. I take small dry powder samples for quick screening instead of mixing the whole vial, which greatly cuts peptide waste for my lab.
Hugo Oakley –
I inject fat lab mice once weekly following the product guide. The peptide strength never changes so I don’t adjust injection volumes mid-test. I can scrape tiny dry powder bits for small pilot tests without dissolving the whole vial.
Isaac C. –
This bulk 10-vial pack has a fantastic discounted price. Every vial holds uniform lyophilized powder with no low-potency units. My experimental results stay steady and repeatable from the first vial all the way to the last one.